Indapamida Retard Pensa

Indapamide, the active ingredient in Indapamida Retard Pensa, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to manage hypertension and to reduce fluid accumulation in patients with heart‑failure‑related edema. GNH USA supplies Indapamida Retard Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts as a thiazide‑like diuretic to control blood pressure and fluid balance. - Hypertension: lowers systemic arterial pressure and reduces cardiovascular risk. - Edema associated with heart failure: promotes diuresis to relieve fluid overload. - Peripheral edema: diminishes excess interstitial fluid in the limbs.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Increased urination: more frequent need to void. - Electrolyte disturbances (low potassium): may cause muscle weakness or cramps. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Hyponatremia: low blood sodium levels that can cause confusion or seizures. - Allergic skin reactions: rash, itching, or hives indicating hypersensitivity.

Before initiating therapy, several safety considerations are recommended. - Monitor electrolytes: check potassium and sodium levels regularly. - Assess renal function: evaluate creatinine and eGFR before and during treatment. - Use caution in diabetes: diuretic‑induced glucose changes may occur. - Avoid abrupt discontinuation: tapering reduces risk of rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - Cyclosporine: combined use can heighten nephrotoxic risk. - Antidiabetic sulfonylureas: enhanced hypoglycemic effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure‑lowering effect. - NSAIDs: may reduce diuretic effectiveness and affect kidney function. - Digoxin: possible increase in serum digoxin concentrations.